MannKind to present at upcoming conferences

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 27, 2024 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD)a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with endocrine and rare lung diseases, today announced that Chief Executive Officer Michael Castagna, PharmD, and Chief Financial Officer Chris Prentiss will share updates during informal discussions at three upcoming investor conferences:

Wells Fargo Healthcare Conference 2024 in Boston
Wednesday September 4th
11:00 am Eastern Time